BCL2L1 anticorps

N° du produit ABIN187417

Cet anticorps Souris Monoclonal détecte spécifiquement BCL2L1 dans WB, IF, IHC (p), IHC (fro) et EIA. Il présente une réactivité envers Humain, Souris, Rat et Porc.

Aperçu rapide pour BCL2L1 anticorps (ABIN187417)

Antigène: BCL2L1 (BCL2-Like 1 (BCL2L1))

Reactivité: Humain, Souris, Rat, Porc

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp BCL2L1 est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Enzyme Immunoassay (EIA)

Clone: 2H12

Détail du produit anti-BCL2L1 anticorps

Specificité: Reacts specifically with the Bcl-xL protein. Species Reactivity: Human, mouse and rat. Others not tested.

Immunogène: Synthetic peptide corresponding to aa 3-14 of the human Bcl-xL protein.

Isotype: IgG2a

Information d'application

Indications d'application: Western blot: Use at 1-5 µg/mL. The optimal dilution for a specific application should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Buffer: 100 µg purified IgG at approx. 1 mg/mL. Purified from ascites fluid.

Stock: -20 °C

Détails sur BCL2L1

Antigène: BCL2L1 (BCL2-Like 1 (BCL2L1))

Autre désignation: Bcl-2-like 1

Sujet: Bcl-xL is structurally related to the Bcl-2 gene and is a member of the Bcl-2 family of oncoproteins. Overexpression of Bcl-xL to other Bcl-2 members is believed to promote cell survival, its ratio to other Bcl-2 family members is believed to modulate the apoptotic process.

Pathways: Apoptose, Negative Regulation of intrinsic apoptotic Signaling